THE ROLE OF NOVEL SUBSTITUTED DIINDOLYL METHANE ANALOGUES IN THE TREATMENT OF TRIPLE-NEGATIVE AND ERBB2-POITIVE BREAST CANCER

$1,356,500FY2011Department of DefenseDOD

Florida A & M University

Investigators